UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

JAMA : the journal of the American Medical Association, 1999-07, Vol.282 (2), p.137

1999

Volltextzugriff (PDF)

Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1

The Journal of infectious diseases, 1996-02, Vol.173 (2), p.340-348

1996

Volltextzugriff (PDF)

A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers

The Journal of infectious diseases, 1999-08, Vol.180 (2), p.290-298

1999

Volltextzugriff (PDF)

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers

AIDS (London), 1998-12, Vol.12 (18), p.2407-2415

1998

Volltextzugriff (PDF)

Safety profile of phase I and II preventive HIV type 1 envelope vaccination : Experience of the NIAID AIDS vaccine evaluation group

AIDS research and human retroviruses, 1997-09, Vol.13 (14), p.1163-1177

1997

Volltextzugriff (PDF)

Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines

The Journal of infectious diseases, 1998-02, Vol.177 (2), p.310-309

1998

Volltextzugriff (PDF)

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3

AIDS research and human retroviruses, 1998-10, Vol.14 Suppl 3, p.S325-S331

1998

Volltextzugriff (PDF)

Immunization with Envelope MN rgp120 Vaccine in Human Immunodeficiency Virus-Infected Pregnant Women

The Journal of infectious diseases, 1999-10, Vol.180 (4), p.1080-1088

1999

Volltextzugriff (PDF)

Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher- and Lower-Risk Volunteers

The Journal of infectious diseases, 2001-05, Vol.183 (9), p.1343-1352

2001

Volltextzugriff (PDF)

Safety and Immunogenicity of a Fully Glycosylated Recombinant gp160 Human Immunodeficiency Virus Type 1 Vaccine in Subjects at Low Risk of Infection

The Journal of infectious diseases, 1993-12, Vol.168 (6), p.1387-1395

1993

Volltextzugriff (PDF)

QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans

Vaccine, 2001-02, Vol.19 (15), p.2080-2091

2001

Volltextzugriff (PDF)

HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers

AIDS research and human retroviruses, 2001-08, Vol.17 (12), p.1175-1189

2001

Volltextzugriff (PDF)

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors

Vaccine, 2001-09, Vol.19 (32), p.4703-4709

2001

Volltextzugriff (PDF)

Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial

Journal of acquired immune deficiency syndromes (1999), 2004-11, Vol.37 (3), p.1385-1392

2004

Volltextzugriff (PDF)

Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults

Journal of Clinical Microbiology, 1990-11, Vol.28 (11), p.2539-2550

1990

Volltextzugriff (PDF)

Immunity to Influenza in Older Adults with Chronic Obstructive Pulmonary Disease

The Journal of infectious diseases, 2004-07, Vol.190 (1), p.11-19

2004

Volltextzugriff (PDF)

Comparison of Systemic and Mucosal Delivery of 2 Canarypox Virus Vaccines Expressing either HIV-1 Genes or the Gene for Rabies Virus G Protein

The Journal of infectious diseases, 2004-04, Vol.189 (7), p.1221-1231

2004

Volltextzugriff (PDF)

Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study

Vaccine, 2003-05, Vol.21 (17), p.2133-2144

2003

Volltextzugriff (PDF)

Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A

Journal of acquired immune deficiency syndromes (1999), 2002-03, Vol.29 (3), p.254-261

2002

Volltextzugriff (PDF)

Influenza Virus Vaccination of Patients With Chronic Lung Disease

Chest, 1997-11, Vol.112 (5), p.1221-1233

1997

Volltextzugriff (PDF)

Vaccination of Vaccinia-Naive Adults with Human Immunodeficiency Virus Type 1 gp160 Recombinant Vaccinia Virus in a Blinded, Controlled, Randomized Clinical Trial

The Journal of infectious diseases, 1992-08, Vol.166 (2), p.244-252

1992

Volltextzugriff (PDF)

Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza Vaccine

Clinical infectious diseases, 2003-01, Vol.36 (2), p.169-174

2003

Volltextzugriff (PDF)

Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults

Chest, 1991-10, Vol.100 (4), p.977-984

1991

Volltextzugriff (PDF)

Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies

Vaccine, 1999-12, Vol.18 (9), p.835-849

1999

Volltextzugriff (PDF)

Phase I/II trials of preventive HIV vaccine candidates. Dose and schedule : summary

AIDS research and human retroviruses, 1994, Vol.10, p.S141-S143

GORSE, G. J

1994

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)
Mit Volltextzugriff
(176)

Publikationsform

Artikel
(223)
Tagungsberichte
(8)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(128)
Life Sciences & Biomedicine
(103)
Humans
(90)
Biological And Medical Sciences
(62)
Infectious Diseases
(51)
Adult
(49)
Middle Aged
(49)
Male
(46)
Microbiology
(46)
Immunology
(45)
Female
(42)
Medical Sciences
(40)
Aids/hiv
(39)
Virology
(35)
Aids Vaccines - Immunology
(33)
Fundamental And Applied Biological Sciences. Psychology
(33)
Hiv-1 - Immunology
(33)
Human Immunodeficiency Virus 1
(30)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(28)
Double-Blind Method
(27)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1

A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers

Safety profile of phase I and II preventive HIV type 1 envelope vaccination : Experience of the NIAID AIDS vaccine evaluation group

Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3

Immunization with Envelope MN rgp120 Vaccine in Human Immunodeficiency Virus-Infected Pregnant Women

Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher- and Lower-Risk Volunteers

Safety and Immunogenicity of a Fully Glycosylated Recombinant gp160 Human Immunodeficiency Virus Type 1 Vaccine in Subjects at Low Risk of Infection

QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans

HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors

Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial

Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults

Immunity to Influenza in Older Adults with Chronic Obstructive Pulmonary Disease

Comparison of Systemic and Mucosal Delivery of 2 Canarypox Virus Vaccines Expressing either HIV-1 Genes or the Gene for Rabies Virus G Protein

Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study

Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A

Influenza Virus Vaccination of Patients With Chronic Lung Disease

Vaccination of Vaccinia-Naive Adults with Human Immunodeficiency Virus Type 1 gp160 Recombinant Vaccinia Virus in a Blinded, Controlled, Randomized Clinical Trial

Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza Vaccine

Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults

Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies

Phase I/II trials of preventive HIV vaccine candidates. Dose and schedule : summary

Suchergebnisse filtern